Anabola androgena steroider biverkningar

Five randomized clinical trials (including mainly men with alcoholic hepatitis and/or cirrhosis) were identified. Only one trial was assessed as adequate regarding all methodological quality components. Anabolic-androgenic steroids versus placebos or no intervention demonstrated no significant effects on mortality (relative risk [RR] = , 95% CI = -), liver-related mortality (RR = , 95% CI = -), complications to the liver disease (RR = , 95% CI = -), liver histology, and a number of other outcome measures. Anabolic-androgenic steroids were not associated with a significantly increased risk of nonserious adverse events, but with the seldom occurrence of serious adverse events (RR = ,95% CI = -).

Anabola androgena steroider biverkningar

anabola androgena steroider biverkningar

Media:

anabola androgena steroider biverkningaranabola androgena steroider biverkningaranabola androgena steroider biverkningaranabola androgena steroider biverkningaranabola androgena steroider biverkningar